Incidental angiofibromas prompt a diagnosis of multiple endocrine neoplasia type-1 (MEN-1).

IMPORTANCE We believe this to be the first documented report of multiple endocrine neoplasia type-1 (MEN-1) in which the diagnosis was suspected based purely on cutaneous findings. The patient was initially referred to the dermatology department for cosmetic concerns and had no overt symptoms, laboratory abnormalities, or known family history of MEN-1. OBSERVATIONS The patient is a 28-year-old man who was referred to the dermatology department for evaluation and removal of skins lesions, later confirmed by biopsy to be facial angiofibromas and a truncal collagenoma. This combination of cutaneous findings was suspicious for a genodermatosis and genetic testing subsequently confirmed the diagnosis of MEN-1. The patient was referred for appropriate follow up and surveillance. CONCLUSIONS AND RELEVANCE This case highlights the importance of vigilance on the part of dermatologists to be aware of subtle skin findings that may be characteristic of rare disorders and may have gone unrecognized by other providers and the patients themselves. In this respect, dermatologists are in a unique position given their specialized training in the recognition of inherited skin disorders. An early diagnosis of an inherited disorder, especially one with increased risk of malignancy, can allow for appropriate surveillance and potentially alter the course of the disease.

[1]  W. Harmsen,et al.  Are Patients with Multiple Endocrine Neoplasia Type I Prone to Premature Death? , 2000, World Journal of Surgery.

[2]  J. Bilezikian,et al.  Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). , 2012, The Journal of clinical endocrinology and metabolism.

[3]  R. Thakker,et al.  Multiple endocrine neoplasia type 1. , 1999, Endocrine-related cancer.

[4]  J. Ahn,et al.  A Case of Familial Cutaneous Collagenoma , 2011, Annals of dermatology.

[5]  J. Moss,et al.  Dermatologic Manifestations of Tuberous Sclerosis Complex (TSC) , 2010 .

[6]  D. Kwiatkowski,et al.  Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics , 2010 .

[7]  J. Stein,et al.  Eruptive collagenomas. , 2010, Dermatology online journal.

[8]  M. Rothmund,et al.  Age‐related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers , 2007, Clinical endocrinology.

[9]  T. Darling,et al.  Rapidly growing collagenomas in multiple endocrine neoplasia type I. , 2007, Journal of the American Academy of Dermatology.

[10]  M. C. Machado,et al.  The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1. , 2007, Clinics.

[11]  J. McNiff,et al.  Multiple facial angiofibromas: a cutaneous manifestation of Birt-Hogg-Dubé syndrome. , 2005, Journal of the American Academy of Dermatology.

[12]  R. Jensen,et al.  Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1. , 2004, The Journal of clinical endocrinology and metabolism.

[13]  R. B. van der Luijt,et al.  Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening? , 2003, European journal of endocrinology.

[14]  A. Vortmeyer,et al.  Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene. , 1998, The Journal of investigative dermatology.

[15]  S. Steinberg,et al.  Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. , 1997, Archives of dermatology.

[16]  L. Requena,et al.  Multiple sclerotic fibromas of the skin , 1992, Journal of cutaneous pathology.